Clin2
NCT07835529Possibly a fitNot yet recruiting

Magnesium treatment for newborns with birth asphyxia

Duration of HospitalizationNeonatal Mortality Rate

Treatments studied

This trial tests whether giving magnesium sulphate to newborns with birth asphyxia (lack of oxygen at birth) can help them recover faster and shorten their hospital stay.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
72 people
Ages
Up to 1 day
Study type
Interventional

Who can take part

  • Your baby must be full-term, meaning born after 37 weeks of pregnancy.
  • Your baby must be less than 24 hours old at the start of the study.
  • Your baby must have been diagnosed with birth asphyxia (lack of oxygen at birth).
  • Your baby must not have any major birth defects.
  • Your baby must not have a blood infection or metabolic disorder at the time of admission.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07524972Recruiting· Phase 3
Magnesium sulphate to protect babies born very early

This study tests whether giving magnesium sulphate (a mineral treatment) to pregnant women at risk of delivering very early (32–35 weeks) can protect the baby's brain and nervous system. The treatment is given before labor starts.

Ismailia, Ismailia Governorate
NCT07652801Not yet recruiting· Phase 3
Combination treatment for newborn brain injury

This trial tests whether giving both magnesium sulfate and melatonin to newborns with brain injury from lack of oxygen works better than magnesium sulfate alone. The goal is to see if the combination improves recovery and reduces long-term disability.

NCT06322732Recruiting
Better care for newborns with severe asphyxia at birth

This study looks at how routine hospital care for full-term or near-term newborns with severe oxygen deprivation at birth can be improved. It aims to find where care can be optimized to reduce complications.

Paris, Île-de-France Region
NCT04898114Recruiting· Phase 1/Phase 2
Inhaled magnesium and sildenafil for newborn lung blood pressure

This study tests whether breathing in magnesium sulfate and giving sildenafil can improve breathing and lung blood vessel pressure in newborns with persistent pulmonary hypertension. It may help newborns who are having trouble oxygenating despite being on a ventilator.

Sohag
NCT07173855Recruiting· Phase 4
Magnesium replacement in ICU patients

This trial tests whether giving magnesium as part of a standard hospital protocol can lower the risk of irregular heartbeat and improve survival in patients admitted to the intensive care unit.

Ajax, Ontario
NCT06955559Not yet recruiting· Phase 3
Magnesium sulfate for childhood asthma and bronchiolitis

This study tests if giving magnesium sulfate (a mineral supplement) helps children with asthma or bronchiolitis breathe better. It is for children aged 1 month to under 18 years who have these conditions.

Hear when a new Duration of Hospitalization trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.